Montserrat Nácher-Vázquez

Montserrat Nácher-Vázquez

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Carbohydrate Polymers
Verified
Journal Article
Open access
MNMontserrat Nácher-Vázquez
Montserrat Nácher-Vázquez
NBNatalia Ballesteros
Natalia Ballesteros
ÁCÁngeles Canales
Ángeles Canales
SSSylvia Rodríguez Saint-Jean
Sylvia Rodríguez Saint-Jean
SPSara Isabel Pérez-Prieto
Sara Isabel Pérez-Prieto
PGpaloma López García
paloma López García
Viral infections in the aquaculture of salmonids can lead to high mortality and substantial economic losses. Thus, there is industrial interest in new molecules active against these viruses. Here we describe the production, purification, and the physicochemical and structural characterization of high molecular weight dextrans synthesized by Lactobacillus sakei MN1 and Leuconostoc mesenteroides RTF10. The purified dextrans, and commercial dextrans with molecular weights ranging from 10 to 2000kDa, were assayed in infected BF-2 and EPC fish cell-line monolayers for antiviral activity. Only T2000 and dextrans from MN1 and RTF10 had significant antiviral activity. This was similar to results obtained against infectious pancreatic necrosis virus. However the dextran from MN1 showed ten-fold higher activity against hematopoietic necrosis virus than T2000. In vivo assays using the MN1 polymer confirmed the in vitro results and revealed immunomodulatory activity. These results together with the high levels of dextran production (2gL(-1)) by Lb. sakei MN1, indicate the compounds potential utility as an antiviral agent in aquaculture.

1 March 2013 in Carbohydrate Polymers
Verified
Journal Article
Closed access
SNSara Notararigo
Sara Notararigo
MNMontserrat Nácher-Vázquez
Montserrat Nácher-Vázquez
IIIdoia Ibarburu
Idoia Ibarburu
MWMª Laura Werning
Mª Laura Werning
PPPilar Fernández de Palencia
Pilar Fernández de Palencia
APAlicia Prieto
Alicia Prieto

1 July 2017 in Carbohydrate Polymers
Verified
Journal Article
Open access
MNMontserrat Nácher-Vázquez
Montserrat Nácher-Vázquez
IIIñaki Iturria
Iñaki Iturria
KZKenza Zarour
Kenza Zarour
MMMari Luz Mohedano
Mari Luz Mohedano
RARosa Aznar
Rosa Aznar
PGpaloma López García
paloma López García
In this work we have investigated two dextran-producing lactic acid bacteria, Lactobacillus sakei MN1 and Leuconostoc mesenteroides RTF10, isolated from fermented meat products. These bacteria synthesise dextran when sucrose, but not glucose, is present in the growth medium. The influence of dextran on bacterial aggregation, adhesion and biofilm formation was investigated in cultures challenged with sucrose or glucose. For Lb. sakei MN1, the synthesis of the dextran drastically impaired the three processes; in contrast it had no effect on Lc. mesenteroides RTF10. Therefore, the influence of dextran on probiotic properties of Lb. sakei MN1 was tested in vivo using gnotobiotic zebrafish models. The bacterium efficiently colonised the fish gut and inhibited the killing activity of Vibrio anguillarum NB10[pOT11]. Furthermore, under conditions of dextran synthesis, the adhesion of Lb. sakei MN1 to the epithelial cells decreased, without greatly affecting its anti V. anguillarum activity.

1 December 2018 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
MLMarta L. Lima
Marta L. Lima
MAMaría A. Abengózar
María A. Abengózar
MNMontserrat Nácher-Vázquez
Montserrat Nácher-Vázquez
MMMaría P. Martínez-Alcázar
María P. Martínez-Alcázar
CBCoral Barbas
Coral Barbas
LRLuis Rivas
Luis Rivas
Drug repurposing affords the implementation of new treatments at a moderate cost and under a faster time-scale. Most of the clinical drugs against Leishmania share this origin.

1 January 2017
Verified
Book Chapter
Closed access
KZKenza Zarour
Kenza Zarour
NVNuria Vieco
Nuria Vieco
APAdrian Pérez-Ramos
Adrian Pérez-Ramos
MNMontserrat Nácher-Vázquez
Montserrat Nácher-Vázquez
MMMª Luz Mohedano
Mª Luz Mohedano
PGpaloma López García
paloma López García

22 November 2019 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
PIPaula Martínez de Iturrate
Paula Martínez de Iturrate
VSVictor Sebastián-Pérez
Victor Sebastián-Pérez
MNMontserrat Nácher-Vázquez
Montserrat Nácher-Vázquez
CTCatherine S. Tremper
Catherine S. Tremper
DSDespina Smirlis
Despina Smirlis
CGCarmen Gil
Carmen Gil
Previous reports have validated the glycogen synthase kinase-3 (GSK-3) as a druggable target against the human protozoan parasite Leishmania. This prompted us to search for new leishmanicidal scaffolds as inhibitors of this enzyme from our in-house library of human GSK-3β inhibitors, as well as from the Leishbox collection of leishmanicidal compounds developed by GlaxoSmithKline. As a result, new leishmanicidal inhibitors acting on Leishmania GSK-3 at micromolar concentrations were found. These inhibitors belong to six different chemical classes (thiadiazolidindione, halomethylketone, maleimide, benzoimidazole, N-phenylpyrimidine-2-amine and oxadiazole). In addition, the binding mode of the most active compounds into Leishmania GSK-3 was approached using computational tools. On the whole, we have uncovered new chemical scaffolds with an appealing prospective in the development and use of Leishmania GSK-3 inhibitors against this infectious protozoan. Graphical Abstract